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Hexavalent chromium (Cr) compounds are respiratory carcinogens in humans and animals. Treatment of Chinese hamster ovary cells with 150 and
300 pM sodium chromate (Na2CrO4) for 2 hr decreased colony-forming efficiency by 46 and 92%, respectively. These treatments induced dose-
dependent internucleosomal fragmentation of cellular DNA beyond 24 hr after chromate treatment. This fragmentation pattern is characteristic of
apoptosis as a mechanism of cell death. These treatments also induced an immediate inhibition of macromolecular synthesis and delayed progres-
sion of cells through S-phase of the cell cycle. Cell growth (as evidenced by DNA synthesis) was inhibited for at least 4 days and transcription
remained suppressed for at least 32 hr. Many of the cells that did progress to metaphase exhibited chromosome damage. Chromate caused the
dose-dependent formation of DNA single-strand breaks and DNA-protein cross-links, but these were repaired 8 and 24 hr after removal of the
treatment, respectively. In contrast, Cr-DNA adducts (up to 1/100 base-pairs) were extremely resistant to repair and were still detectable even 5
days after treatment. Compared with other regions of the genome, DNA-protein cross-links and Cr adducts were preferentially associated with the
nuclear matrix DNA of treated cells, which was 4.5-fold enriched in actively transcribed genes. Chromium adducts, formed on DNA in vitro at a
similar level to that detected in nuclear matrix DNA, arrested the progression of a DNA polymerase in a sequence-specific manner, possibly
through the formation of DNA-DNA cross-links. Total RNA and mRNA synthesis and induction of expression of the inducible GRP78 gene were
suppressed in a concentration- and time-dependent manner by chromate. The effects of chromate on GRP78 induction correlated most closely
with the presence of DNA-protein cross-links but suppression of total RNA and mRNA synthesis correlated with the presence of DNA-Cr adducts
in cells. These results suggest that the persistent Cr-DNA adducts may be responsible for the protracted cell cycle delay and transcriptional inhibi-
tion caused by chromate. Escape from apoptosis may be one of the steps involved in chromate-induced carcinogenesis. - Environ Health
Perspect 102(Suppl 3):159-167 (1994).
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Introduction
Hexavalent (VI) chromium compounds are
carcinogenic to humans, potent inducers of
tumors in experimental animals (1,2), and
can neoplastically transform cells in culture
(3-5). They are also genotoxic (4,6,7) and
can induce a spectrum of DNA damage
(8-13), gene mutations (4,5,7), sister
chromatid exchanges (4,14), and chromo-
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somal aberrations (4,15). The mechanisms
by which hexavalent chromium-induced
toxicity and carcinogenicity are mediated
is, however, currentlypoorly understood.
Potentially, carcinogen toxicity may
occur by one of two mechanisms: necrosis
or apoptosis (16). These two types of cell
death differ morphologically and biochem-
ically. Necrotic cells exhibit an early char-
acteristic cell swelling with the loss of the
ionic gradient across the cell membrane
and subsequent DNA degradation by
released lysosomal enzymes (17). Necrotic
cell death does not appear to be cell cycle
related. In contrast, cells dying by apoptosis
undergo shrinkage while the ionic gradient
across the cell membrane is maintained until
later stages ofthe apoptotic process (18). A
characteristic feature of apoptosis is that
DNA is fragmented internucleosomally
before the loss of cell membrane integrity
occurs. This is believed to result from the
activation of a nuclear, Ca2+/Mg2+-depen-
dent or pH-sensitive endonuclease, possi-
bly DNase 11 (16,19). In many cases the
process of apoptosis appears related to
arrest ofcells in a distinct phase ofthe cell
cycle (18,20,21). Carcinogen-treated cells
that do overcome the cell cycle block may
begin the process oftumor formation, sug-
gesting that apoptosis could serve as a
method ofescape from the process ofmul-
tistage carcinogenesis initiated by genotoxic
agents.
Recently, several carcinogenic and
chemotherapeutic agents, including methyl-
prednisolone, 4-hydroxytamoxifen, metho-
trexate, 5-fluorouracil, 5-fluorodeoxyuridine,
etoposide, N-methyl-N'-nitro-N-nitroso-
guanidine, cisplatin, y-irradiation, and
nitrogen mustard, have been shown to
induce apoptosis (18,20-24). Recent studies
in this laboratory have sought to understand
the role of apoptosis in hexavalent
chromium-induced toxicity and carcino-
genicity. Treatment of Chinese hamster
ovary (CHO) cells with toxic doses of
sodium chromate was found to result in an
immediate inhibition ofcell growth, and in
macromolecular synthesis; however, cell
Environmental Health Perspectives 159MANNINGETAL
death was delayed for at least 24 hr.
Between 24 and 72 hr post-treatment, con-
siderable cell death occurred following an
accumulation ofcells in the S-phase ofthe
cell cyde. Manyofthe cells thatdidprogress
to metaphase exhibited chromosome dam-
age. Intemudeosomal fagmentation ofcel-
lular DNAwas detected beyond 24 hr after
chromate treatment. This fragmentation
pattern is characteristic of apoptosis as a
mechanism of cell death. Although treat-
ment with 150 pM chromate induced sev-
eral types ofDNAdamage, onlychromium
adducts remained unrepaired throughout
the period when cell death occurred. This
lesion was found to be preferentially associ-
ated with the nudear matrix, the putative
site of replication and transcription in the
cell (25). Chromium-DNA adducts formed
on a synthetic DNA template in vitro
inhibited progression of a DNA poly-
merase in a dose-dependent manner. These
results suggest that the persistent
chromium-DNA adducts may be responsi-
ble for the protracted cell cyde delay and
transcriptional inhibition caused by chro-
mate. They also suggest that potentially,
escape from chromate-induced apoptosis
may be one of the steps involved in chro-
mate-induced carcinogenesis.
Materials and Methods
CAl Cukue,Chroma e Treamnt, and
CytouityAssys
CHO AA8 cells were cultured as monolay-
ers as described previously (13). Cells were
treated with 150 or 300 PM Na2CrO4 for
2 hr in complete medium.
Cytotoxicity Assays. Cytotoxicity was
assayed by measuring reduction in plating
efficiency relative to controls. Two hundred
cells were seeded in 5 ml of basal media
Eagle's onto 60 mm dishes and allowed to
grow for 17 hr. Cultures were treated with
Na2CrO4 for 2 hr. After treatment the
medium was removed, cells were washed
with PBS and then refedwith 5 ml offresh
medium. Seven to 10 days later colonies
were stained with crystal violet and
counted. Experiments were performed in
triplicate. There were three replicates per
treatment group in each experiment.
DNA Fragmentation Analyis. Cellular
DNA was analyzed by the method of
Martikainen et al. (26). Cell pellets were
suspended in 5 ml of 10 mM Tris-Cl pH
8.0, 0.5% (v/v) Triton X-100, 5 mM
EDTA, 0.5% sodiumdodecyl sulfate (SDS),
and digested with 300 pglml proteinase K
for 18 hr at 37°C. After digestion, the
DNA was sequentially extracted with phe-
nol, phenol/chloroform, chloroform, and
ethanol precipitated. Purified DNA (10 pg)
was electrophoresed on a 1.6% agarose gel.
The gel was stained with 0.5 gml ethid-
ium bromide in 10 mM Tris-Cl pH 8.0, 1
mM EDTA, 0.5 mg/ml ofRNase A for 4
to 16 hrand photographed.
Karyotype Analysis. Chromosome
preparations and scoring of individual
types ofdamage were as described byWise
etal. (15).
Measurement of Macromolecular
Synthesis. To measure DNA and protein
synthesis, cells were pulse labeled with 1
pCi/ml [methyl_3H]thymidine (60-90
Ci/mmole, ICN Biomedicals, Inc., Costa
Mesa, CA) or 1 pCi/ml [35S]methionine
(1000 Ci/mmole, ICN Biomedicals) for 1 hr.
Cells were harvested and counted using a
model Zf Coulter counter. Incorporation
of radioactivity into cellular macromole-
cules (cpm/cell) was determined by scintil-
lation counting ofacid-insoluble material
by the method of Lehmann and Stevens
(27). RNAsnthesis was essed by incor-
poration of[ H]uridine into total cytoplas-
mic RNA or mRNA as described
previously (13). GRP78 transcript levels
were determined by Northern blot
hybridization analysis as described by
Manningetal. (13).
PreparatonofNudeiandNudear
Matrix a on
CHO cells were suspended in RSB buffer
(10 mM Tris, pH 7.4, 10 mM NaCl, 3
mM MgCl2, 1 mM phenyl methyl sulfonyl
fluoride [PMSF]) and incubated on ice for
20 min. Nonidet P-40 (Sigma Chemical
Co., St Louis, MO) was added to a final
concentration of0.05% and the cells were
homogenized with 10 to 12 strokes of a
glass-teflon homogenizer. The nuclei were
collected by centrifisgation (750xg, 40C
for 5 min), and washed twice with RSB
containing 0.25 M sucrose. Finally, nudei
were separated from whole cells by cen-
trifugation at 75,000xg, 4°C for 1 hr
through a cushion of 1.8 M sucrose in
RSB. Nudear pellets were stored at -80°C
until required. Chromatin fractionations
were performed essentially as described by
Obi et al. (28) with minor modifications.
PMSF (1 mM) was added to each buffer
immediately before use. Purified CHO
nudei (20 OD12. units in 0.1 M NaOH)
were suspended in 1 ml of micrococcal
nudease digestion buffer (10 mM Tris-Cl,
pH 7.4, 25 mM KCI, 5 mM MgCl2, 0.5
mM CaC12, and 0.35 M sucrose) and
digested with 1 to 2 pg(ml ofmicrococcal
nuclease (Sigma) at 370C for 5 min.
Digestions were terminated by the addition
of EGTA to a final concentration of 3
mM. The nudei were pelleted (14,00Oxg,
2 min, 40C) and the supematant decanted
to a fresh tube. The pellets were sequen-
tially extracted with 1 ml of 10 mM Tris-
Cl pH 7.4, 0.2 mM MgCl2 and 1 ml of10
mM Tris-Cl, pH 7.4, 2 M NaCl, 0.2 mM
MgCl2for 15 min on ice. In each case the
supernatant, containing solubilized chro-
matin, was decanted to a fresh tube. The
final pellet obtained, containing the residual
nudearmatrixfraction, waswashedwith 1%
Triton X-100, 10 mM Tris-Cl pH 7.4, 0.2
mM MgCl2 to remove nudearmembranes.
AnalysisofDNADamage
Analysis of DNA damage by alkaline elu-
tion was performed by the method of
Kohn et al. (29,30) as previously described
byPatiemo etal. (10,13,31).
DNA-protein cross-links were isolated
from whole nudei and nudear matrix frac-
tions were prepared from cells which had
been prelabeled with 0.5 pCi/ml of trans-
[35S]metabolic labeling reagent (a mixture
ofL-[35 ]methionine and L- 35S]cysteine;
1066 Ci/mM, ICN Biomedicals) for 24 to
48 hr prior to treatment with Na2CrO4.
Samples were mixed with 15 vol of urea
extraction buffer (8 M urea, 1% Triton X-
100, and 10 mM Tris, pH 7.4) and rocked
for 4 hr at room temperature. These mix-
tures were then applied to a Qiagen tip-
500 column (Qiagen, Chatsworth, CA)
which had been equilibrated with 10 ml of
buffer A (0.75 M NaCl, 50 mM MOPS,
pH 7.0, 15% ethanol, 0.15% Triton X-
100, and0.1 mM PMSF). Thecolumn was
then washed with 30 ml ofbuffer B (1 M
NaCl, 50 mM MOPS, pH 7.0, 15%
ethanol, and 0.1 mM PMSF). DNA and
urea-resistant DNA-associated proteins
wereelutedwith 15 ml ofbuffer C (1.25 M
NaCl, 50 mM Tris, pH 8.2, 15% ethanol,
and 0.1 mM PMSF). The eluted fractions
were further extracted with 2% SDS
overnight rocking at room temperature.
DNA and DNA-protein cross-links were
recovered from the retentate after filtration
through Centricon-100 filters (Amicon,
Beverly, MA) at 1000xgfor 30 min. DNA
was quantified spectroscopically from its
absorbance at 260 nm. The specific activity
(35S/pg DNA) of the Centricon filtration
retentate was determined by scintillation
counting. The datawereexpressed as aratio
of the specific activity (cpm/pg DNA) of
DNA-protein cross-links recovered from
treated cells over that obtained with control
cells in the sameexperiment.
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To measure the formation ofchromium-
DNA adducts, CHO cells were treated
with [5Cr]-labeled sodium chromate.
Chromium bound to DNA purified from
whole cells; nudei and nudear matrix frac-
tions were quantified by scintillation
counting as described previously (13).
In Vi" BiingofChrm ium (ll)
toDNA
Chromium (III) chloride (Sigma Chemical
Co.) was dissolved in 10 mM Tris-Cl, pH
7.6, immediately before use. pSV2neoTS
DNA (7 pg) at a concentration of840 pM
DNA-phosphate was treated with CrCl3 in
a total volume of25 pl for 16 hr at room
temperature. For polymerase arrest assays,
chromium-treated template DNA was
denatured with 0.2 M NaOH at 370 C for
30 min. Unbound chromium was removed
by passing samples over Chromaspin-30
columns in nuclease-free water (Clontech
Laboratories Inc., Palo Alto, CA). To mea-
sure chromium binding, DNA was treated
with 5lCrC13 (specific activity 200-900
Ci/g Cr; ICN Biomedicals). Following
treatment, samples were diluted 50-fold in
10 mM Tris, pH 7.6, and aliquots were pre-
cipitated with an equal volume of 20%
trichloroacetic acid (TCA) on ice for 5 min.
The precipitated sample was applied to a
GF/C glass microfiber filter (Whatman
International Ltd., Maidstone, England)
under vacuum. Filters were sequentially
washed with 10% TCA (15 ml), 100%
ethanol (5 ml), and air dried. The filters
were scintillation counted using the tritium
channel of a Beckman LS 7000 scintilla-
tion counter (Beckman Instruments, Inc.,
Fullerton, CA). To measure counting effi-
ciency, aliquots of a dilution series of
51CrCl3 were also applied to filters, air
dried, and scintillation counted. Data were
expressed as mmole of5ICr molecules
bound per mole ofDNA-phosphate.
Poymweraserr Assay
Asynthetic 88-bp template was synthesized
using a Cyclone Plus DNA Synthesizer
(Millipore, Bedford, MA) (Figure 7)) and
cloned into the plasmid pSV2neo using
standard techniques (32) at the site created
by digestion ofthe vector with Eco RI and
Bam HI restriction endonudeases to gen-
erate pSV2neoTS. A 25-base oligonu-
deotide primer [5'-CGTATCACGAGGC-
CCTIT-l CGTCTTC-39 complementary to
the region two bases upstream ofthe muta-
tional target sequence was synthesized. Ten
pmole ofprimer were end-labeled with 1 p1
of[Y-32P]-ATP (20 pmole, 170 pCi) (ICN
Biochemicals) in a total volume of 20 pl
containing 2 1pl of IOxT4 polynucleotide
kinase buffer (400 mM Tris-Cl, pH 7.5,
100 mM MgCl2, 50 mM DTI), and 1 pl
(8 units) of T4 polynucleotide kinase
(Promega, Madison, WI) at 370C for 10
min. The reaction was stopped by incubat-
ing tubes at 900C for 2 min and the
labeled primer was stored at -20°C. An
aliquot of chromium-treated, denatured
pSV2neoTS (2 pg in 7 pl) was combined
with 2 pl ofstop-assay reaction buffer (200
mM Tris-Cl, pH 7.5, 50 mM MgC12, 250
mM NaCl) and 1 pl ofend-labeled primer
(0.5 pmole). This mixture was heated to
65°C for 2 min and cooled slowly to below
300C. After annealing, each reaction was
mixed with 1 pl of0.1 M DTT, 2.5 pl of
water and 2 pl of Sequenase Version 2.0
T7 polymerase (United States Biochemical,
Cleveland, OH) diluted 1:8 in the manu-
facturer's enzyme dilution buffer (10 mM
Tris-Cl, pH 7.5, 5 mM DTT, 0.5 mg/ml
bovine serum albumin). The tubes were
mixed well, briefly centrifuged, and 3.5 pl
of each mixture was transferred to fresh
tubes containing 2.5 pl of 160 pM each of
dATP, dCTP, dTTP, and dGTP. These
elongation reactions were incubated at
450 C for 5 min. Stop solution (4 pl of
95% formamide, 20 mM EDTA, 0.05%
bromophenol blue, 0.05% xylene cyanol
FF) was then added and the tubes heated
to 78°C for 2 min and placed on ice.
Aliquots ofeach reaction (2 p1l) were ana-
lyzed on a 6% denaturing polyacrylamide
sequencing gel. To determine the position
ofpolymerase arrests, sequencing reactions
ofthe DNA template were also analyzed on
the same gel. Gels were run for approxi-
mately 2 hr at 2000 V in 1 xTBE buffer
(0.045 M Tris-borate, 1 mM EDTA).
Followingelectrophoresis, gels werewrapped
in cellophane and exposed to X-ray films
between two intensifying screens for 5 to
17 hr at-700C.
Results
Tarcity,and Effects onCdlGrowth
Treatment of CHO cells with 150 or
300 pM Na2CrO4 for 2 hr reduced colony-
forming efficiency by 46 and 92%, respec-
tively compared with untreated controls
(not shown). Colonies in chromate-treated
cultures were notably smaller than the cor-
responding untreated control colonies indi-
cating that cell growth had been inhibited
(not shown). Consistent with this observa-
tion, Figure 1 shows that immediately after
treatment with sodium chromate the
growth of CHO cells was suppressed.
There was, however, no decrease in the
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matefor2 hr. Cells were harvested at variousbmes after
this treatm andduplicatesampleswerecounted with a
model Zf Coulter counter. These data are representative
ofthreeindependentexperiments.
number of adherent cells for at least 24 hr.
Between days 1 and 3 after treatment the
number of adherent cells in the 150- and
300-pM treatment groups decreased by 35
and 85%, respectively, indicating that con-
siderable cell death occurred during this
period. In both treatment groups greater
than 95% of adherent and nonadherent
cells excluded trypan blue up to at least
48 hr suggesting that extensive cell lysis had
not occurred during this period. By 72 hr,
none ofthe nonadherent cells excluded try-
pan blue, indicating that they were no
longerviable. The number ofadherent cells
did not begin to increase until at least
5 days after treatment.
Analysis ofGenomicDNA
Genomic DNA prepared from pooled
unattached and adherent cells at various
times after treatment with Na2CrO4 was
analyzed by agarose gel electrophoresis
(Figures 2, 3). DNAisolated from untreated
cells was ofhigh molecular weight (greater
than 24 kb) and unfragmented at all times
examined (Figures 2, 3). Up to 24 hr after
chromate treatment, little DNA fagmenta-
tion was apparent (Figure 2) even on
highlyoverloadedgels (notshown). In con-
trast, dose-dependent internucleosomal
DNA fragmentation, indicative of apopto-
sis, was detectable 48 hr after treatment of
cells with either 150 or 300 pM chromate
(Figure 2). By 72 hr posttreatment a con-
siderable amount of DNA fragmentation
was apparent in both treatment groups
(Figure 3). Comparison ofthe size offrag-
mented genomic DNA with molecular
weight marker DNA indicated that the
average size difference between the DNA
fagments was approximately 180 bp. This
fragmentation pattern is consistent with
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Figure 2. Analysis of genomic DNA isolated from CHO
cells up to 48 hr after treatment with sodium chromate.
Cells were treated with 0, 150, or 300 pM chromate for
2 hr. Either immediately after this treatment (0 hr), 24 or
48 hr later, DNA was isolated from pooled adherent and
nonadherent cells and analyzed on a 1.6% agarose gel.
Molecular weight markers were a 123 bp ladder (Gibco,
BRL, Gaithersburg, MD). These data are representative of
five independentexperiments.
that expected to result from the internucle-
osomal DNA cleavage that occurs during
apoptotic cell death (16). Seven days
(168 hr) after chromate treatment, no
DNA fragmentation was apparent, suggest-
ing that the process ofapoptosis was com-
pleted in these cell populations by this time
(Figure 3).
Efets onMacrmolecuarSynthesis
Figure 4 shows the residual DNA synthesis
occurring in Na2CrO4-treated CHO cells
expressed as a percentage ofthat occurring
in logarithmic phase control cells.
Treatment with 150 and 300 pM chromate
for 2 hr immediately suppressed DNA syn-
thesis to 30 and 10% of control values,
respectively. This inhibition continued for
at least 4 days in both treatment groups. By
day 5, there was some recovery ofDNAsyn-
thesis, to 70 and 50% ofcontrolvalues in the
150 and 300 pM treated cells, respectively.
Figure 5 shows the effect of Na2CrO4
on the synthesis of cytoplasmic RNA and
mRNA in CHO cells expressed as a percent-
age of that occurring in control cells. The
extent of [3H]uridine incorporation into
total cytoplasmic RNA and mRNA in a
1 hr pulse was measured up to 32 hr after
treatment with Na2CrO4. Treatment with
150 and 300 pM chromate suppressed
total RNA synthesis by approximately 50
to 60% and 75 to 90%, respectively com-
pared with controls (Figure 5). These con-
centrations also suppressed mRNA synthesis
to approximately 30 and 20% of control
levels, respectively (Figure 5). Suppression
of transcription of both total and mRNA
synthesis occurred immediately after treat-
ment (13) and this suppression persisted
for at least 32 hr (Figure 5).
Chromate was found to inhibit the
induction of expression of the inducible
GRP78 gene (33) by tunicamycin in a
time- and concentration-dependent man-
ner. CHO cells were exposed to 150 or
300 pM chromate for 2 hr. At various
times after this treatment, cultures were
incubated with tunicamycin for 8 hr to
induce GRP78 gene expression. Increases
in GRP78 mRNA levels were measured by
Northern blot hybridization analysis.
Immediately after treatment of cells with
150 and 300 pM chromate, induction of
GRP78 expression was suppressed to
approximately 10 and 2% ofthat occurring
in nonchromate treated cells, respectively
(Figure 5, 8-hr column). In contrast, 24 hr
after treatment with 150 pM chromate,
there was a partial recovery of GRP78
inducibility to approximately 56% of that
occurring in untreated cells (Figure 5, 32-
hr column). There was, however, no induc-
tion of GRP78 expression in cultures
treated with 300 pM chromate at this time.
Chromate-Induced DNADamage
DNA damage induced in CHO cells by
2 hr of treatment with 150 or 300 pM
Na2CrO4 was measured by alkaline elu-
tion. DNA single-strand breaks (13) and
DNA-protein cross-links (Figure 6A) were
detected immediately after treatment of
cells with chromate. The single-strand
breaks were essentially repaired within 8 hr
(13). DNA-protein cross-links were more
persistent but were repaired in cells treated
with 150 pM chromate by 24 hr after
treatment (Figure 6A). Cells treated with
the 300 pM dose contained a much
reduced level of cross-links at 24 hr com-
pared with 0 hr, indicating that DNA
repair had occurred.
Figure 6B shows that chromium-DNA
adducts were formed immediately after
treatment of cells with [51Cr]-labeled
Na2CrO4. After a slight reduction in
adduct levels between 0 and 8 hr post-
treatment, little further decrease occurred
up to at least 32 hr (Figure 6B).
Chromium-DNA adducts and DNA-
protein cross-links isolated from the nuclei
and nuclear matrix of CHO cells treated
with 150 pM chromate were quantified.
Immediately after treatment with chro-
mate, chromium-DNA adducts were
markedly enriched in the nuclear matrix
(approximately 4-fold compared with total
nuclear DNA) (Table 1). Twenty-four
hours after treatment, chromium-DNA
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Fgure 3 Analysis of genomic DNA isolated from CHO
cells 3 days (72 hr) and 7 days (168 hr) after treatment
with 0, 150, or 300 pM chromate for 2 hr. DNA was iso-
lated from pooled adherent and nonadherent cells and
analyzed on a 1.6% agarose gel. Molecularweight mark-
ers were a 123 bp ladder(Gibco, BRL, Gaithersburg, MD).
These data are representative of three independent
experiments.
adducts were still enriched in nuclear
matrix DNA but at a slightly decreased
level compared with 0 hr. Consistent with
the data presented in Figure 6B; however,
there was little decrease in adduct levels in
total nuclear DNA (Table 1). Chromium-
induced DNA-protein cross-links, which
were stable to 8 M urea and 2% SDS, were
also enriched in the nuclear matrix
(Table 1). Consistent with the alkaline elu-
tion data presented in Figure 6A, the
matrix-associated cross-links reached a
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Figure 4. The effect of sodium chromate on DNA synthe-
sis in CHO cells. Cells were treated with the indicated
concentrations of sodium chromate for 2 hr and then
transferred to fresh medium. For 1 hr before the indicated
times, cells were incubated with [3H]thymidine to assess
DNA synthesis. [3Hlthymidine incorporation (cpm/cell)
occurring in chromate-treated cells is presented as a per-
cent of that occurring in logarithmic phase control cells
(broken line). These data represent three independent
experiments.
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Figure 5. Cells were treated with 150 or300 pM Na2CrO4for 2 hrand then transferred to fresh medium (0 hr). For 1 hr
priortothe indicated times, cells were incubated in the presence of[3HJuridine to assesstotal cytoplasmic RNAsynthe-
sis and messenger RNA synthesis. Transcription occurring in chromate-treated cells was expressed as a percentage of
that occurring in control cultures atthe same time ± SEM oftwo to four independent experiments. Either immediately
after treatment with chromate (0 hr) or 24 hr later, cells were incubated with 10 pg/ml tunicamycin for 8 hr to induce
GRP78expression. Atthe end ofthese incubation periods(8and 32 hr, respectively), RNAwas isolated and GRP78tran-
script levels were assayed by Northern blot hybridization analysis. Results are expressed as a percentage of the
increase in GRP78 mRNA levels occurring in nonchromate-treated control cells exposed to tunicamycin ± SEM ofthree-
determinations. Datareproducedwith permission from Manining etal.(13).
Table 1. Chromium-DNA adductand DNA-protein cross-link levels inCHO cellstreatedwith 150 pM chromatefor2 hr.a
Chromium adducts/DNA phosphate(mmole/mole)
Time aftertreatment, hr Total nuclear DNA Nuclearmatrix DNA
0 1.05±0.19 3.86±0.93
24 0.84 ±0.25 2.57 ± 0.22
Relative DNA-protein cross-link levelsb
Untreatedcontrolc 1 6.56 ±2.60
0 2.15±0.38 12.84±0.78
24 1.92 ±0.44 8.87 ± 0.65
aThe presented data are the mean ± SE of two to four determinations in each case. bDNA-protein cross-links stable to
extraction with urea and SDSwerequantified as described in Materials and Methods. CResults were standardized tothe
value obtained with nonchromate-treated, unfractionated nuclei in each experiment. The level of protein bound to the
nuclearmatrixof untreated cells isalso shown.
Table 2. Clastogenicity ofsodium chromate.a
Concentration ofsodium chromate(pM) 0 150
Percent metaphaseswith damage 2 ± 1 33 ±0
Aberrations per 100 metaphases 2 ± 1 47 ± 5
Chromatid lesionsb 2 ± 1 38±3
Isochromatid lesionsc 0 4± 0
Chromatid exchange 0 3± 2
Dicentrics 0 1 1
Triradial figures 0 2 0
Quadraradial figures 0 1 ± 1
aResults are the average of two experiments ± range (100 metaphases analyzed perexperiment). bAchromatic lesions
maximum level at the end ofthe 2 hr treat-
ment but were mostly repaired 24 hr later.
Chromate-Induced Chromosome
Damage
Table 2 shows that chromosomes prepared
from metaphase CHO cells 24 hr after 2 hr
of treatment with 150 jM Na2CrO4 con-
tained high levels of damage (33% of
metaphases with damage) compared with
chromosomes obtained from untreated
controls (2% metaphases with damage). A
high percentage of cells that manifested
damage also contained multiple chromoso-
mal aberrations. Metaphase chromosomes
could not be obtained 24 hr after treatment
ofcells with 300 pM chromate.
Effects on in VitroReplication
To investigate the effect of chromium-
DNA adducts on in vitroreplication, a syn-
thetic 88 bp DNA template was synthesized
and cloned into the Eco Ri-Bam Hi site
of the plasmid pSV2neo to form
pSV2neoTS. The sequence ofthis template
is shown in Figure 7 and includes a 24 bp
sequence 67% enriched in AT residues, -a
17 bp sequence 100% enriched in GC
residues, and a 17 bp self-complementary
inverted repeat. These unique regions were
included in the target sequence because
each had been demonstrated to be particu-
larlysusceptible to chemical mutation (34).
The plasmid pSV2neoTS was linearized
by digestion with Not I to generate a dis-
crete 105 bp full length elongation product
in the polymerase arrest assay. Linearized
plasmid was treated at a concentration of
840 PM with 0, 35, 105, 210, 420, or 840
pM CrCl3 for 16 hr at room temperature.
These doses are lower than the intracellular
concentration of chromium occurring in
CHO cells treated with 150 jiM Na2CrO4
for 2 hr which was determined to be 5.2
mM (Xu J, Manning FCR, Patierno SR,
unpublished). They are also comparable to
the intracellular concentration of
chromium occurring in cells treated with
lead chromate for 24 hr (35). The selected
treatments correspond to DNA-phosphate:
Cr3+ ratios of 1:0, 1:0.04, 1:0.13, 1:0.25,
1:0.5, and 1:1, respectively. After denatura-
tion with NaOH and removal ofunbound
chromium by passage over Chromaspin-30
chromatography columns, the treated
DNA was analyzed by polymerase arrest
assay using Sequenase Version 2.0 T7
DNA polymerase. Few arrests occurred
when untreated DNAwas used as a template
in this assay. The majority of synthesized
DNA was of a size that corresponded to
the expected 105 bp full-length fragment
(Figure 7, control lane). In contrast, treat-
ment of pSV2neoTS with CrCl3 resulted
in the concentration-dependent synthesis
of truncated DNA molecules and a reduc-
tion in the amount of full-length product
(Figure 7, 35 to 840 FM lanes). Comparison
of the size of these truncated molecules
with the corresponding sequencing reac-
tions (Figure 7; G, A, T, and C lanes) indi-
cated that the polymerase arrests occurred
in a sequence-specific manner, in the GC-
rich (100% GC) and palindromic (65%
GC) sequences and to a lesser extent in the
AT-rich region (27% GC). This effect was
most pronounced after treatment with the
lower concentrations of CrCl3 (Figure 7,
35 and 105 jiM lanes). The template
sequence prior to the AT-rich region, in
which a number of arrests occurred, is also
enriched in GC (61%). At the highest con-
centrations of CrCl3 employed, almost
every base was affected to some extent
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Table3. Binding ofchromium (III)totemplate DNA in vitro.
CrCI3,ljMa 35 105 210 420 840
Crbindong,rnmole_mole
DNA-phosphate 5±3 23±5 57±3 96±9 169±9
aDNAat a concentration of840p!yl DNA-phosphate wastreated with the indicated concentrations ofCrCI3for 16 hrat
roomtemperature. ±edata arethe average ±therangeoftwo independentexperiments.
(Figure 7, 420 and.840 pM lanes).Adentical
polymerase arrests west detectedwhen heat
denaturation was substitmted for alkaline
denat4fation in the:arrest assay (36).
Treatment ofpSV2n6oTS with concentra-
tions of [5ICr]-labeled CrCl3 that pro-
duced polymerase arrests indicated that
chromium-DNA adducts were formed on
template DNA in a dose-dependent man-
ner (Table 3).
Discussion
The mechanisms of toxicity and carcino-
genicity of hexavalent chromium com-
pounds are currently poorly understood.
Recently, however, several carcinogenic
agents have been reported to induce apop-
totic cell death in mammalian cells
(18,20-24). Studies in this laboratory have
therefore investigated whether apoptosis
could be a mechanism bywhich chromium
(VI) toxicity is mediated.
Treatment ofCHO cells with cytotoxic
concentrations ofNa2CrO4 for 2 hr imme-
diately inhibited cell growth (Figure 1) and
DNA synthesis (Figure 4), however no
immediate cell death, as judged by trypan
blue exclusion, occurred. Rapid inhibition
ofDNA replication by chromate has previ-
ously been reported by Levis et al. (37).
Bakke et al. (38) have previously reported
that cells treated with chronic, high con-
centrations of chromate arrest in S-phase.
0 5 10 15 20 25 30 35
Time After Oorrmate Treatment "i
J
In agreement with these observations, 24 hr
after treatment with 150 pM chromate,
cells were found to accumulate in the S-
phase of the cell cycle (not shown). An S-
phase delay has also been reported after
treatment ofcells with the toxic metal salts,
CdCI2 and NiCI2 (39). In addition, nitro-
gen mustard blocks progression of cells
through this phase ofthe cell cycle prior to
the onset ofapoptosis (21).
Many of the cells that did progress to
metaphase exhibited a high level of chro-
mosome damage 24 hr after treatment with
150 pM chromate (Table 2). The majority
of the damage observed were chromatid
lesions. These results are consistent with
our previous finding that the relatively
insoluble hexavalent chromium salt, lead
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Figure 6. Formation and repair of DNA damage in
Na2CrO4 -treated CHO cells. Cells were treated with 150
or 300 pM Na2CrO4 for 2 hr and then were refed with
fresh medium (0 hr). DNA-protein cross-links (A) were
measured by alkaline elution at the indicated times after
this treatment. To assess chromium adduct formation,
cells were incubated with [51Crjlabeled Na2CrO4 and the
amountofradioactivity associated withtotal cellular DNA
determined (B). Error bars represent the SEM of three
independent experiments. Data reproduced with permis-
sionfrom Manning etal. (13).
Mutational Target Sequence
3'
templat- strand
Fgure7.Analysis ofchromium(lll)treated DNAbypolymerase arrest assay. The plasmid pSV2neoTS wastreated with
the indicated concentrations CrCI3 and replicated in vitrowith Sequenase Version 2.0T7 DNApolymerase. The products
ofthese reactions wereanalyzed on a sequqncing gel. Also shown are the corresponding sequencing reactions(G, A. T,
and C lanes).The lowerpanel showsthe sequence ofthesynthetictemplate used inthese reactions.
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chromate, is clastogenic to CHO cells
(15). Metaphase chromosomes could not
be obtained 24 hr after treatment with
300 pM chromate. This may be due to the
extreme suppression ofDNAsynthesis pro-
duced by this dose (Figure 4). In agree-
ment with this possibility, although cells
treated with 150 ,uM chromate grew
slightly in the 24 hr following treatment,
no growth was detected after treatment with
the 300 FM concentration (Figure 1) (13).
A characteristic feature of apoptosis is
that genomic DNA is fragmented intemu-
cleosomally before the loss of cell mem-
brane integrity occurs (18). The size of
DNA isolated from chromate-treated
CHO cells was therefore analyzed on agarose
gels. Dose-dependent internucleosomal
DNA fragmentation was detected 48 hr
after treatment of cells with Na2CrO4
(Figure 2). Beyond 24 hr, a large number
of cells became detached from the culture
dishes (Figure 1). However, the membranes
of these cells excluded trypan blue until
between 48 and 72 hr after treatment. This
is consistent with the known parameters of
apoptotic cell death (16). By 72 hr after
treatment with either 15 or 300 pM chro-
mate, considerable internudeosomal DNA
fragmentation was apparent (Figure 3),
suggesting that a large number ofcells were
undergoing apoptosis at this time.
Following a protracted inhibition of
growth, chromate-treated cells began to
recover, as evidenced byincreased DNAsyn-
thesis on day 5 after treatment (Figure 4).
This was followed by an increase in cell
number between days 6 and 8 (Figure 1).
By day 7 after treatment, no DNA frag-
mentation was detected (Figure 3) suggest-
ing that cells were no longer undergoing
apoptosis at this time.
Treatment ofCHO cells with 150 and
300 pM Na2CrO4 produced an immediate
inhibition of protein synthesis (40). Al-
though the role of protein synthesis in
apoptosis is unclear, the protein synthesis
inhibitor cycloheximide has been reported
toinduceapoptosis in some instances (41). It
isthereforepossible thattheinhibition ofpro-
tein synthesis produced by chromate could
be involved in the initiation ofapoptosis.
The formation and repair of DNA
damage oi chromate-treated CHO cells was
examined. DNA single-strand breaks,
DNA-protein cross-links, and chromium
DNA adducts were formed in a concentra-
tion-dependent manner; subsequently each
type ofdamage was repaired at a different
rate. Single-strand breaks were rapidly
repaired, essentially within 8 hr (13). The
DNA-protein cross-links were more persis-
tent than the strand breaks but were also
repaired. By 24 hr no cross-links remained
in cells treated with 150 pM chromate,
while cells exposed to the 300 pM dose
contained considerably lower levels of this
type ofdamage at this time (Figure 6A).
The most persistent form ofdamage was
chromium-DNA adducts that remained
unrepaired for at least 32 hr (Figure 6B).
This was the only type ofdamage to persist
after the onset of cell death induced by
both 150 and 300 pM chromate. In fact,
adducts were still detectable in cells 5 days
after treatmentwith the 150 pM dose (13).
Potentially therefore, chromium-DNA
adducts could be involved in the mechanism
of chromate-induced toxicity or carcino-
genicity. Alternatively, DNA single-strand
breaks or DNA-protein cross-links,
although repaired prior to the onset ofcell
death, may cause the induction of a signal
that induces cells to undergo apoptosis. A
further possibility is that free radicals, pro-
duced as a result ofthe intracellular reduc-
tion of hexavalent chromium (8,42-44),
maytrigger apoptosis in affected cells.
Compared with total nuclear DNA,
chromium-DNA adducts were found to be
enriched in the nuclear matrix of CHO
cells both immediately after treatment with
150 pM Na2CrO4 and 24 hrlater (Table 1).
Both these data and those presented in
Figure 6B suggest that chromium-DNA
adducts are very poorly repaired in CHO
cells.
The nudear matrix is believed to be the
site of replication in the cell (25).
Potentially, chromium-DNA adducts asso-
ciated with this fraction could interfere
with replication and hence cause the inhi-
bition of DNA synthesis and cellular
growth observed after treatment of cells
with Na2CrO4 (Figures 1, 4). One mecha-
nism by which this may occur would be if
chromium-DNA adducts inhibited the
action of DNA polymerases. To test this
possibility, the effect of chromium-DNA
adducts on the in vitro replication ofDNA
by Sequenase Version 2.0 T7 DNA poly-
merasewas examined. For these experiments
a synthetic template containing GC- and
AT-rich regions and a palindrome sequence
(pSV2neoTS) was employed. A reduced
trivalent form of chromium is believed to
be the species which binds to cellular DNA
(45). Treatment ofpSV2neoTS with CrCl3
resulted in the dose-dependent formation
of truncated molecules (Figure 7). After
treatment with relatively low concentra-
tions of CrCl3 (35, 105, and 210 pM),
these polymerase arrests occurred preferen-
tially in the GC-rich regions ofthe template
molecule. This is consistentwith the known
affinity of chromium binding for guanine
residues (46). Notably, DNA treated in
vitrowith 35 pM CrCI3 contained asimilar
level ofadducts (Table 3) to that detected
in the nudear matrix of cells treated with
150 pM chromate (Table 1).
Recent data obtained in this laboratory
suggest that the CrCI3-induced polymerase
arrests may result from the formation of
DNA-DNA cross-links (36). A similar
inhibition ofpolymerase action via the for-
mation of chromium (III)-induced DNA-
DNA cross-links has previously been
reported by Snow and Xu (45). DNA-
DNA cross-links formed in the nuclear
matrix may therefore be a potential mecha-
nism by which the chromate-induced inhi-
bition ofDNAsynthesis is mediated.
As an alternative to the alkaline elution
technique (29,30) we have developed a
procedure to isolate and quantify DNA-
protein cross-links that are stable to
sequential extraction with urea and SDS
(XuJ, Manning FCR, Patierno SR, unpub-
lished). Using this procedure, chromium-
induced DNA-protein cross-links were
detected predominantly in the nuclear
matrix fraction immediately after treatment
ofcells with 150 pM Na2CrO4 (Table 1).
Preferential cross-linking ofnudear matrix
proteins to DNA has also been reported by
other workers (47,48). Consistent with the
alkaline elution data presented in Figure
6A, the cross-links in the nuclear matrix
reached a maximum level immediately after
treatment with 150 pM Na2CrO4 but were
essentiallyrepaired 24 hrlater (Table 1).
Treatment of CHO cells with 150 or
300 pM Na2CrO4 suppressed both total
RNA and mRNA synthesis for at least
32 hr (Figure 5). In cells treated with the
lower chromate concentration, DNA-
chromium adducts were the only damage
which persisted over this entire period
(Figure 6B). In vitro, binding ofchromium
(III) has been found to interfere with the
function of DNA templates, causing an
increased number ofinitiation sites and the
formation of truncated transcription prod-
ucts (49). The chromium adducts formed in
CHO cells may therefore exert an inhibitory
effect on transcription, possibly by interfer-
ingwith the action ofRNApolymerases.
Immediately after treatment with
150 pM chromate, induction ofexpression
of the inducible gene GRP78 by tuni-
camycin was almost completely inhibited
(Figure 5). In contrast, by 24 hr after treat-
ment a recovery in GRP78 induction
occurred (Figure 5). This recovery corre-
latedwith the repair ofDNA-protein cross-
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links at this time (Figure 6A; Table 1) but
not with a general recovery ofRNA synthe-
sis (Figure 5). Repair of single-strand
breaks did not result in a recovery of
GRP78 induction (13). These results are
similar to those of Hamilton and
Wetterhahn (47) who reported that
dichromate inhibited induction of the
inducible genes 5-aminolevinate synthase
and cytochrome PB1 P450 in chick embryo
liver in vivo and that this inhibition corre-
lated with the presence of DNA-protein
cross-links.
It has been suggested that transcription
ofinducible genes may be particularly sen-
sitive to DNA-protein cross-link formation
because these genes typically have complex
regulatory regions and often require
numerous DNA-protein interactions for
proper gene expression (50). Potentially
therefore, DNA-protein cross-links formed
within the GRP78 promoter may inhibit
the action of transacting factors required
for gene induction. In fact, a number of
transcription-factor binding sites, which
are required for inducible gene expression,
have been identified within the promoter
region ofthe GRP78 gene (51-54). DNA-
protein cross-links occurred predominantly
in the nuclear matrix fraction after treat-
ment with 150 pM chromate (Table 1);
and repair of these cross-links 24 hr after
treatment correlated with recovery of
GRP78 induction (Figure 5; Table 1,
respectively). It is therefore interesting that
the nuclear matrix fraction was found to be
enriched in GRP78 gene sequences com-
pared with total nuclear DNA (Xu J,
Manning FCR, Patierno SR, unpublished
observations).
Only a partial recovery of GRP78
induction (56%) occurred when DNA-
protein cross-links were repaired 24 hr
after treatment with 150 pM chromate
(Figure 5). This suggests that chromium-
DNA adducts, which were the only DNA
damage still detectable at this time (Figure
6B; Table 1), may contribute to the
observed inhibition of GRP78 induction.
Alternatively, this effect may be due to the
large number ofcells undergoing apoptosis
beyond 24 hr (Figure 1). In cells treated
with 300 pM chromate, no recovery of
GRP78 induction occurred even 24 hr
after treatment (Figure 5), probably
because of the extreme toxicity of this
dose.
The results presented in this study indi-
cate that the toxicity of hexavalent
chromium compounds can occur via apop-
tosis. Cells which do not undergo apopto-
sis may contain chromate-induced
chromosome damage in genes associated
with tumor formation such as oncogenes
or tumor suppressor genes. Escape from
chromate-induced apoptosis could there-
fore represent an early step in chromate-
induced carcinogenesis.
REFERENCES
1. IARC. Chromium, Nickel andWelding. IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans No 49, Lyon:
International Agency for Research on Cancer, 1990.
2. LandolphJR. Neoplastic transformation ofmammalian cells by car-
cinogenic metal compound: cellular and molecular mechanisms.
Biological Effects of Heavy Metals, Vol 2 (Foulkes EC, ed).
Florida:CRC Press, 1990; 1-18.
3. Elias Z, Poirot 0, Pezerat H, Suquet H, Schneider 0, Daniere
MC, Terzetti F, Baruthio F, Fournier M, Cavelier C. Cytotoxic
and neoplastic transforming effects of industrial hexavalent
chromium pigments in Syrian hamster embryo cells. Carcinogenesis
10:2043-2052 (1989).
4. Leonard A. Mechanisms in metal genotoxicity: significance of in
vitroapproaches. Mutat Res 198:321-326 (1988).
5. Patierno SR, Banh D, Landolph JR. Transformation of
C3H/1OT1/2 mouse embryo cells to focus formation and anchor-
age independence by insoluble lead chromate but not soluble cal-
cium chromate: relationship to mutagenesis and internalization of
lead chromate particles. Cancer Res 48:5280-5288 (1988).
6. Cohen M, Latta D, Coogan T, Costa M. Mechanisms ofmetal car-
cinogenesis: the reactions of metals with nucleic acids. In:
Biological Effects of Heavy Metals, vol 2 (Foulkes EC, ed).
Florida:CRC Press, 1990; 19-75.
7. De Flora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of
chromium compounds. A review. Mutat Res 238:99-172 (1990).
8. Standeven AM, Wetterhahn KE. Chromium (VI) toxicity: uptake,
reduction, and DNA damage. J Am Cell Toxicol 8:1275-1283
(1989).
9. Sugiyama M, Patierno SR, Cantoni 0, Costa M. Characterization
ofDNA lesions induced by CaCrO4 in synchronous and asynchro-
nous cultured mammalian cells. Mol Pharmacol 29:
606-613 (1986).
10. XuJ, Wise JP, Patierno SR. DNA damage induced by carcinogenic
lead chromate particles in cultured mammalian cells. Mutat Res
280:129-136 (1992).
11. Hamilton JW, Wetterhahn KE. Chromium(VI)-induced DNA
damage in chick embryo liver and blood cells in vivo.
Carcinogenesis 7:2085-2088 (1986).
12. Miller CA III, Costa M. Characterization of DNA-protein com-
plexes induced in intact cells by the carcinogen chromate. Mol
Carcinog 1:125-133 (1988).
13. Manning FCR, Xu J, Patierno SR. Transcriptional inhibition by
carcinogenic chromate: relationship to DNA damage. Mol
Carcinog 6:270-279 (1992).
14. Montaldi A, Zentilin L, Paglialunga S, Levis AG. Solubilization by
nitrilotriacetic acid (NTA) of genetically active Cr(VI) and Pb(II)
from insoluble metal compounds. J Toxicol Environ Health
21:387-394 (1987).
15. Wise JP, Leonard JC, Patierno SR. Clastogenicity oflead chromate
particles in hamster and human cells. Mutat Res 278:69-79 (1992).
16. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of
apoptosis. Int RevofCytol 68:251-306 (1980).
17. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an
historical perspective. In: Apoptosis: The Molecular Basis of Cell
Death (Tomei LD, Cope FO, eds). Plainview:Cold Spring Harbor
Press, 1991; 5-29.
18. Barry MA, Behnke CA, Eastman A. Activation ofprogrammed cell
death (apoptosis) by cisplatin, other anticancer drugs, toxins, and
hyperthermia. Biochem Pharmacol 40:2353-2362 (1990).
19. Eastman A, Barry M. Platinum and Other Metal Coordination
Compounds in Cancer Chemotherapy. (Howell SB, ed.) New
York:Plenum Press, 1991.
20. Musche RJ, Zhang HB, Iliakis G, McKenna WG. Cyclin B expres-
sion in hela cells during the G2 block induced by ionizing radia-
tion. Cancer Res 51:5113-5117 (1991).
21. O'Connor PM, Wassermann K, Sarang M, Magrath I, Bohr VA,
Kohn, KW. Relationship between DNA cross-links, cell cycle, and
apoptosis in Burkett's lymphoma cell lines differing in sensitivity to
nitrogen mustard. Cancer Res 51:6550-6557 (1991).
22. Corcoran GB, Ray SD. Contemporary issues in toxicology. The
role ofthe nucleus and other compartments in toxic cell death pro-
duced by alkylating hepatotoxicants. Toxicol and Appl Pharmacol
113:167-183 (1992).
23. Eastman A. Activation of programmed cell death by anticancer
agents: cisplatin as a model system. Cancer Cells 2:275-280 (1990).
24. Kasten MB, Onyekewere 0, Sidransky D, Vogelstein B, Craig RW.
Participation of protein in the cellular response to DNA damage.
Cancer Res 51:6304-6311 (1991).
25. Georgiev GP, Vassetzky YS, Luchnik AN, Chernokhvostov VV,
Razin SV. Nuclear skeleton, DNA domains and control ofreplica-
tion and transcription. EurJ Biochem 200:613-624 (1991).
26. Martikainen P, Kyprianou N, Tucker RW, Isaacs JT. Programmed
166 Environmental Health PerspectivesINDUCT7ONOFAPOPTOSIS BYCARCINOGENICCHROMATE
cell death ofnon-proliferating androgen-independent prostatic can-
cer cells Cancer Res 51:4693-4700 (1991).
27. Lehmann AR, Stevens S. A rapid procedure for measurement of
DNA repair in human fibroblasts and for complementation analysis
ofxeroderma pigmentosum cells. Mutat Res 69:177-190 (1980).
28. Obi FO, Ryan AJ, Billett MA. Preferential binding ofthe carcino-
gen benzo[a]pyrene to DNA in active chromatin and the nuclear
matrix. Carcinogenesis 7:907-913 (1986).
29. Kohn WK, Ewig RAG, Erickson LC, Zwelling LA. Measurement
of strand breaks and cross-links by alkaline elution. In: DNA
Repair: A Laboratory Manual of Research Procedures, (Friedberg
EC, Hanawalt PC, eds). NewYork:Marcel Dekker, 1981; 379-401.
30. Ewig RAG, Kohn K. DNA-protein cross-linking and DNA inter-
strand cross-linking by haloethylnitroureas in L1210 cells. Cancer
Res 38:3197-3203 (1978).
31. Patierno SR, Sugiyama M, Basilion J, Costa M. Preferential DNA-
protein cross-linking by NiCI2 in magnesium-insoluble regions of
fractionated Chinese hamster ovary cells. Cancer Res
45:5787-5794 (1985).
32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a labora-
torymanual. NewYork.Cold Spring Harbor Laboratory Press, 1989.
33. Dorner AJ, Wasle, LC, Raney P, Haugejorden S, Green M,
Kaufman RJ. The stress response in Chinese hamster ovary cells. J
Biol Chem 265:22029-22033 (1990).
34. Warpehoski MA, Hurle LH. Sequence selectivity ofDNA covalent
modification. Chem ResToxicol 1:315-333 (1988).
35. Wise JP, Orenstein JM, Patierno SR. Inhibition oflead chromate
clastogenesis by ascorbate: relationship to particle dissolution and
uptake. Carcinogenesis 14:429-434 (1993).
36. Bridgewater LC, Manning FCR, Wood ES, Patierno SR. DNA
polymerase arrest by adducted trivalent chromium. Mol Carcinog
9:122-133 (1994).
37. Levis AG, Buttignol M, Bianchi V, Sponza G. Effects ofpotassium
dichromate on nucleic acid and protein synthesis and on precursor
uptake in BHKfibroblasts. Cancer Res 38:110-116 (1978).
38. Bakke 0, Jakobsen K, Eik-Nes KB. Concentration dependent
effects of potassium dichromate on the cell cycle. Cytometry
5:482-486 (1984).
39. Costa M, Cantoni 0, de Mars M, Swartzendrube DE. Toxic metals
produce an S-phase-specific cell cycle block. Res Commun Chem
Pathol Pharmacol 38:405-419 (1982).
40. Blankenship LJ, Manning FCR, Orenstein JM, Patierno SR.
Apoptosis is the mode of cell death caused by carcinogenic
chromium. ToxicolApplied Pharmacol 126:(1994), in press.
41. Leger JG, Montpetit ML, Tenniswood MP. Characterization and
cloning of androgen-repressed mRNAs from rat ventral prostate.
Biochem Biophys Res Commun 147:196-203 (1987).
42. Klein CB, Frenkel K, Costa M. The role ofoxidative processes in
metal carcinogenicity. Chem Res Toxicol 4:604-615 (1991).
43. Kasprzak KS. The role ofoxidative damage in metal carcinogenic-
ity. Chem Res Toxicol 4:604-615 (1991).
44. Standeven AM, Wetterhahn KE. Is there a role for reactive oxygen
species in the mechanism of chromium(VI) carcinogenesis. Chem
Res Toxicol 4:616-625(1991).
45. Snow ET, Xu L-S. Chromium(III) bound to DNA templates pro-
motes increased polymerase processivity and decreased fidelity dur-
ing replication in vitro. Biochemistry 30:11238-11245 (1991).
46. Tsapakos MJ, Wetterhahn KE. The interaction ofchromium with
nucleic acids. Chem Biol Interact 46:265-277 (1983).
47. Miller CA III, Cohen MD, Costa M. Complexing of actin and
other nuclear proteins to DNA by cis-diamminedichloroplatinum
(II) and chromium compounds. Carcinogenesis 12:269-276
(1991).
48. Wedrychowski A, Ward WS, Schmidt WN Hnilica LS.
Chromium-induced cross-linking of nuclear proteins and DNA. J
Biol Chem 260:7150-7155 (1985).
49. Okada S, Taniyama M, Ohba H. Mode ofenhancement in ribonu-
cleic acid synthesis directed bychromium (III)-bound deoxyribonu-
cleic acid. J Inorg Biochem 17:41-49 (1982).
50. Hamilton JW, Wetterhahn KE. Differential effects of chromium
(VI) in constitutive and inducible gene expression in chick embryo
liver in vivo and correlation with chromium(VI)-induced DNA
damage. Mol Carcinog 2:274-286 (1989).
51. Li X, Lee AS. Competitive inhibition ofa set ofendoplasmic reticu-
lum protein genes (GRP78, GRP94, and ERp72) retards cell
growth and lowers viability after ionophore treatment. Mol Cell
Biol 11:3446-3453 (1991).
52. Chang SC, Wooden SK, Nakaki T, Kim YK, Lin AY, Kung L,
Attenello JW, Lee AS. Rat gene encoding the 78kDa glucose-regu-
lated protein GRP78: its regulatory sequences and the effect ofpro-
tein glycosylation on its expression. Proc Natl Acad Sci USA
84:680-684 (1987).
53. Resendez E Jr, Wooden S, Lee AS. Identification ofhighly con-
served domains and protein-binding sites in the promoters of the
rat and human genes encoding the stress-inducible 78-kilodalton
glucose regulate[protein. Mol Cell Biol 8:4579-4584 (1988).
54. Liu ES, Lee AS. Common sets of nuclear factors binding to the
conserved promoter motifoftwo coordinately regulated ERprotein
genes, GRP78 and GRP94. NuclAcids Res 19:5425-5431 (1991).
Volume 102, Supplement3, September 1994 167